Cream4349

XERS Sept 10th PDUFA potential run up.

Panjang
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well.

I marked the resistance and support points that I think are major. There are no triangles to work off of only resistance and support points as well as moving averages. I will look to re-buy when i see a strong reversal from either the 9.30 or 10.50 areas. GLTA!

Hope you enjoy!

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.